Prof. KADOTA

• Professor
  • Kyuichi KADOTA, M.D., Ph.D.
• Associate Professor
  • Futoshi SUIZU, Ph.D.
• Assistant Professor
  • Emi IBUKI, M.D., Ph.D.
  • Mina NAGAO,Ph.D
• Technical Staff
  • Keiko YAMAKAWA, Ph.D.

・Carcinogenesis and aging in cancer
・Morphologic evaluation of cancer cells
・Molecular targeting therapy

• Intratumoral administration of CHST15 siRNA remodels tumoral stroma and tumor-draining lymph nodes and augments tumor-infiltrating T cells in pancreatic cancer in mice. Ye J, Suizu F, Yamakawa K, Mukai Y, Yoneyama H, Kondo J, Kato M, Nishiyama A, Yahagi N, Kadota K. Mol Ther Oncol. 2024 Apr; in press
• Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy. Ibuki E, Kadota K, Kimura N, Ishikawa R, Oshima M, Okano K, Haba R. Heliyon. 2023 Dec 19;10(1)
• Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.Matsuda Y, Ye J, Yamakawa K, Mukai Y, Azuma K, Wu L, Masutomi K, Yamashita T, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Kojima M, Kaneko S, Haba R, Kontani K, Kanaji N, Okano K, Muto-Ishizuka M, Yokohira M, Saoo K, Imaida K, Suizu F. J Natl Cancer Inst. 2023 Feb 8;115(2):208-218
  

E-Mail:

 >> Lab Homepage